CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-14 | Reardon Andrew CLO & Secretary | Grant or award | +6,928 | 29,462 | ||
| 2025-02-14 | Reardon Andrew CLO & Secretary | Shares withheld for taxes | −2,775 | $120.00 | $333K | 26,687 |
| 2025-02-14 | Reardon Andrew CLO & Secretary | Grant or award | +5,429 | 32,116 | ||
| 2025-02-14 | Reardon Andrew CLO & Secretary | Shares withheld for taxes | −1,758 | $120.00 | $211K | 30,358 |
| 2025-01-17 | KOZARICH JOHN W Director | Option exercise | +2,406 | $52.30 | $126K | 46,181 |
| 2025-01-17 | KOZARICH JOHN W Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,406 | 0 | ||
| 2024-12-23 | Espinoza Octavio Chief Financial Officer | Sale | −2,104 | $116.37 | $245K | 20,647 |
| 2024-12-05 | Espinoza Octavio Chief Financial Officer | Shares withheld for taxes | −1,859 | $123.51 | $230K | 22,751 |
| 2024-11-27 | LAMATTINA JOHN L Director | Option exercise | +2,406 | $52.30 | $126K | 31,921 |
| 2024-11-27 | LAMATTINA JOHN L Director | Sale | −2,406 | $123.65 | $298K | 29,515 |
| 2024-11-27 | LAMATTINA JOHN L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,406 | 0 | ||
| 2024-09-23 | Reardon Andrew CLO & Secretary | Option exercise | +2,000 | $52.27 | $105K | 24,534 |
| 2024-09-23 | Reardon Andrew CLO & Secretary | Sale | −2,000 | $99.60 | $199K | 22,534 |
| 2024-09-23 | Reardon Andrew CLO & Secretary | Option exercise · Employee Stock Option (right to buy) | −2,000 | 70,944 | ||
| 2024-09-23 | Korenberg Matthew E President & COO | Option exercise | +395 | $49.99 | $20K | 51,172 |
| 2024-09-23 | Korenberg Matthew E President & COO | Option exercise | +9,377 | $52.84 | $495K | 60,549 |
| 2024-09-23 | Korenberg Matthew E President & COO | Sale | −2,481 | $100.05 | $248K | 58,068 |
| 2024-09-23 | Korenberg Matthew E President & COO | Sale | −7,090 | $101.61 | $720K | 50,978 |
| 2024-09-23 | Korenberg Matthew E President & COO | Sale | −201 | $102.05 | $21K | 50,777 |
| 2024-09-23 | Korenberg Matthew E President & COO | Option exercise · Employee Stock Option (right to buy) | −395 | 0 |
Page 18 of 43 · 858 trades